-
1
-
-
0003405565
-
-
Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L, Edwards BK: SEER Cancer Statistics Review 1973-1998, 2001
-
(2001)
SEER Cancer Statistics Review 1973-1998
-
-
Ries, L.A.G.1
Eisner, M.P.2
Kosary, C.L.3
Hankey, B.F.4
Miller, B.A.5
Clegg, L.6
Edwards, B.K.7
-
2
-
-
0029163088
-
Breast cancer: Cause and prevention
-
Hulka BS, Stark AT: Breast cancer: cause and prevention. Lancet 346: 883-887, 1995
-
(1995)
Lancet
, vol.346
, pp. 883-887
-
-
Hulka, B.S.1
Stark, A.T.2
-
3
-
-
0031027636
-
Breast cancer risk associated with gynecologic surgery and indications for such surgery
-
Schairer C, Persson I, Falkeborn M, Naessen T, Troisi R, Brinton LA: Breast cancer risk associated with gynecologic surgery and indications for such surgery. Int J Cancer 70: 150-154, 1997
-
(1997)
Int J Cancer
, vol.70
, pp. 150-154
-
-
Schairer, C.1
Persson, I.2
Falkeborn, M.3
Naessen, T.4
Troisi, R.5
Brinton, L.A.6
-
4
-
-
0030843969
-
Breast cancer and hormone replacement therapy: Collaborative re-analysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer
-
Collaborative Group on Hormonal Factors in Breast Cancer: Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 350: 1047-1059, 1997
-
(1997)
Lancet
, vol.350
, pp. 1047-1059
-
-
-
5
-
-
0027304028
-
Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk
-
Pike MC, Spicer DV, Dahmoush L, Press MF: Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 15: 17-35, 1993
-
(1993)
Epidemiol Rev
, vol.15
, pp. 17-35
-
-
Pike, M.C.1
Spicer, D.V.2
Dahmoush, L.3
Press, M.F.4
-
6
-
-
0034650561
-
Interaction with endothelial cells is a prerequisite for branching ductal-alveolar morphogenesis and hyperplasia of preneoplastic human breast epithelial cells: Regulation by estrogen
-
Shekhar MP, Werdell J, Tait L: Interaction with endothelial cells is a prerequisite for branching ductal-alveolar morphogenesis and hyperplasia of preneoplastic human breast epithelial cells: regulation by estrogen. Cancer Res 60: 439-449, 2000
-
(2000)
Cancer Res
, vol.60
, pp. 439-449
-
-
Shekhar, M.P.1
Werdell, J.2
Tait, L.3
-
7
-
-
0026846928
-
The role of angiogenesis in tumor growth
-
Folkman J: The role of angiogenesis in tumor growth. Semin Cancer Biol 3: 65-71, 1992
-
(1992)
Semin Cancer Biol
, vol.3
, pp. 65-71
-
-
Folkman, J.1
-
8
-
-
0024818355
-
Vascular endothelial growth factor is a secreted angiogenic mitogen
-
Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246: 1306-1309, 1989
-
(1989)
Science
, vol.246
, pp. 1306-1309
-
-
Leung, D.W.1
Cachianes, G.2
Kuang, W.J.3
Goeddel, D.V.4
Ferrara, N.5
-
9
-
-
0033304698
-
Regulation of angiogenic growth factors in the female reproductive tract by estrogens and progestins
-
Hyder SM, Stancel GM: Regulation of angiogenic growth factors in the female reproductive tract by estrogens and progestins. Mol Endocrinol 13: 806-811, 1999
-
(1999)
Mol Endocrinol
, vol.13
, pp. 806-811
-
-
Hyder, S.M.1
Stancel, G.M.2
-
10
-
-
0034086611
-
Identification of functional estrogen response elements in the gene coding for the potent angiogenic factor vascular endothelial growth factor
-
Hyder SM, Nawaz Z, Chiappetta C, Stancel GM: Identification of functional estrogen response elements in the gene coding for the potent angiogenic factor vascular endothelial growth factor. Cancer Res 60: 3183-3190, 2000
-
(2000)
Cancer Res
, vol.60
, pp. 3183-3190
-
-
Hyder, S.M.1
Nawaz, Z.2
Chiappetta, C.3
Stancel, G.M.4
-
11
-
-
0031597992
-
The loss of estrogen and progesterone receptor gene expression in human breast cancer
-
Lapidus RG, Nass SJ, Davidson NE: The loss of estrogen and progesterone receptor gene expression in human breast cancer. J Mammary Gland Biol 3: 85-94, 1998
-
(1998)
J Mammary Gland Biol
, vol.3
, pp. 85-94
-
-
Lapidus, R.G.1
Nass, S.J.2
Davidson, N.E.3
-
12
-
-
0035291168
-
Clinical studies of angiogenesis inhibitors: The University of Texas MD Anderson Center Trial of Human Endostatin
-
Herbst RS, Lee AT, Tran HT, Abbruzzese JL: Clinical studies of angiogenesis inhibitors: the University of Texas MD Anderson Center Trial of Human Endostatin. Curr Oncol Rep 3: 131-140, 2001
-
(2001)
Curr Oncol Rep
, vol.3
, pp. 131-140
-
-
Herbst, R.S.1
Lee, A.T.2
Tran, H.T.3
Abbruzzese, J.L.4
-
13
-
-
0026587657
-
Induction of mammary tumors by expression of polyomavirus middle T oncogene: A transgenic mouse model for metastatic disease
-
Guy CT, Cardiff RD, Muller WJ: Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol Cell Biol 12: 954-961, 1992
-
(1992)
Mol Cell Biol
, vol.12
, pp. 954-961
-
-
Guy, C.T.1
Cardiff, R.D.2
Muller, W.J.3
-
14
-
-
0021061819
-
Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
-
Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63, 1983
-
(1983)
J Immunol Methods
, vol.65
, pp. 55-63
-
-
Mosmann, T.1
-
15
-
-
0034671471
-
Estrogen promotes mammary tumor development in C3(1)/SV40 large T-antigen transgenic mice: Paradoxical loss of estrogen receptor alpha expression during tumor progression
-
Yoshidome K, Shibata MA, Couldrey C, Korach KS, Green JE: Estrogen promotes mammary tumor development in C3(1)/SV40 large T-antigen transgenic mice: paradoxical loss of estrogen receptor alpha expression during tumor progression. Cancer Res 60: 6901-6910, 2000
-
(2000)
Cancer Res
, vol.60
, pp. 6901-6910
-
-
Yoshidome, K.1
Shibata, M.A.2
Couldrey, C.3
Korach, K.S.4
Green, J.E.5
-
16
-
-
0025639984
-
Estrogenic and antiestrogenic down-regulation of estrogen receptor levels: Evidence for two different mechanisms
-
Gyling M, Leclercq G, Heuson JC: Estrogenic and antiestrogenic down-regulation of estrogen receptor levels: evidence for two different mechanisms. J Receptor Res 10: 217-234, 1990
-
(1990)
J Receptor Res
, vol.10
, pp. 217-234
-
-
Gyling, M.1
Leclercq, G.2
Heuson, J.C.3
-
17
-
-
0024521495
-
Multihormone regulation of MMTV-LTR in transfected T-47-D human breast cancer cells
-
Glover JF, Darbre PD: Multihormone regulation of MMTV-LTR in transfected T-47-D human breast cancer cells. J Steroid Biochem 32: 357-363, 1989
-
(1989)
J Steroid Biochem
, vol.32
, pp. 357-363
-
-
Glover, J.F.1
Darbre, P.D.2
-
18
-
-
0028844518
-
The role of ovarian hormones, age and mammary gland development in polyomavirus mammary tumorigenesis
-
Rondinelli RH, Haslam SZ, Fluck MM: The role of ovarian hormones, age and mammary gland development in polyomavirus mammary tumorigenesis. Oncogene 11: 1817-1827, 1995
-
(1995)
Oncogene
, vol.11
, pp. 1817-1827
-
-
Rondinelli, R.H.1
Haslam, S.Z.2
Fluck, M.M.3
-
20
-
-
0030005902
-
Antiangiogenic therapy of transgenic mice impairs de novo tumor growth
-
Parangi S, O'Reilly M, Christofori G, Holmgren L, Grosfeld J, Folkman J, Hanahan D: Antiangiogenic therapy of transgenic mice impairs de novo tumor growth. Proc Natl Acad Sci USA 93: 2002-2007, 1996
-
(1996)
Proc Natl Acad Sci USA
, vol.93
, pp. 2002-2007
-
-
Parangi, S.1
O'Reilly, M.2
Christofori, G.3
Holmgren, L.4
Grosfeld, J.5
Folkman, J.6
Hanahan, D.7
-
21
-
-
0032521153
-
Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis
-
Coughlin CM, Salhany KE, Wysocka M, Aruga E, Kurzawa H, Chang AE, Hunter CA, Fox JC, Trinchieri G, Lee WM: Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis. J Clin Invest 101: 1441-1452, 1998
-
(1998)
J Clin Invest
, vol.101
, pp. 1441-1452
-
-
Coughlin, C.M.1
Salhany, K.E.2
Wysocka, M.3
Aruga, E.4
Kurzawa, H.5
Chang, A.E.6
Hunter, C.A.7
Fox, J.C.8
Trinchieri, G.9
Lee, W.M.10
-
22
-
-
0030035755
-
Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids
-
McLaren J, Prentice A, Charnock-Jones DS, Millican SA, Muller KH, Sharkey AM, Smith SK: Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids. J Clin Invest 98: 482-489, 1996
-
(1996)
J Clin Invest
, vol.98
, pp. 482-489
-
-
McLaren, J.1
Prentice, A.2
Charnock-Jones, D.S.3
Millican, S.A.4
Muller, K.H.5
Sharkey, A.M.6
Smith, S.K.7
|